The presence of TCF7, a single transcription factor in CD8+ T cells, is found to be predictive of clinical response to ICB, suggesting that the state of T cells is critical for the induction of effective tumor immunity, rather than the number or their spatial distribution. The gene discussed is CD8A; the disease is neoplasm.